• Menu
  • Skip to primary navigation
  • Skip to content

Before Header

Header Right

Mobile Menu

RSS
Follow by Email
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet
LinkedIn
LinkedIn
Share
Instagram
  • Algorithms
  • Basics
  • Lectures and Cases
  • Quick Hit Article
  • About US
  • Favoritest Links

Jesse Shriki, DO, MS RDMS FACEP

Droperidol, Ziprasidone or Ativan for Agitation Control in the ED

Droperidol, Ziprasidone or Ativan for Agitation Control in the ED

June 10, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Martel ML, Driver BE, Miner JR, Biros MH, Cole JB. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department. Acad Emerg Med. 2021 Apr;28(4):421-434. doi: 10.1111/acem.14124. Epub 2020 Oct 5. PMID: 32888340. The answer is still Droperidol however given the small sample size this still needs to …

Category: Uncategorized

Pressure Support Or T-Piece Trials

Pressure Support Or T-Piece Trials

June 10, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

There may not be much data on which type of Weaning trial is best..But if there were Id pick this one!

Category: Uncategorized

Prophylactic or Surveillance Splenic artery embolization

Prophylactic or Surveillance Splenic artery embolization

January 20, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: Trauma

A Road Map for TEE

A Road Map for TEE

January 11, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Ever Wondered where to start learning TEE? Well here is a roadmap to help understand the images. Look back soon for more learning! Download the pdf below:

Category: Algorithms

Is there a DIF between H2 and PPI’s in the mechanically ventilated ICU patient

Is there a DIF between H2 and PPI’s in the mechanically ventilated ICU patient

August 25, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: GI, ICU

Only the A-E-I-O-U’s to start RRT and now we know “Y”! The Start-AKI Trial

Only the A-E-I-O-U’s to start RRT and now we know “Y”! The Start-AKI Trial

August 10, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

In residency and med school we are always taught the indications for emergent CRRT as the mnemonic: AEIOU Acidosismetabolic acidosis with a pH < 7.1 Electrolytes hyperkalemia > 6.5 mEq/L refractory to treatment or rapidly rising levels in potassiumIngestionswith dialyzable drug, including salicylates, lithium, isopropanol, methanol, and ethylene glycol (SLIME)Overloadvolume overload that does not respond …

Category: Quick Hit ArticleTag: ICU, Renal

I CAN Drive 65?…In Shock: A Trial of MAP 60-65 in Patients 65 years or older requiring vasopressors

I CAN Drive 65?…In Shock: A Trial of MAP 60-65 in Patients 65 years or older requiring vasopressors

July 29, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  1 Comment

Category: Quick Hit ArticleTag: ICU

Atrial fibrillation in the ICU: Tough AF to Treat, Sick AF to care for…

Atrial fibrillation in the ICU: Tough AF to Treat, Sick AF to care for…

July 28, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Peer Reviewed by Dr. Sagar Dave, DO Every once in a while, it’s a good thing to get down to the nitty gritty of things. I think this is most helpful in common situations. Atrial fibrillation is one of those things to have quickly accessible in your internal brain. In this episode I want to …

Category: AlgorithmsTag: Cardiology, ICU

Conservative vs Interventional Management of Spontaneous Primary Pneumothoracies (PSP)

Conservative vs Interventional Management of Spontaneous Primary Pneumothoracies (PSP)

July 16, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: Emergency Medicine, Pulmonology

COVID-19 RISK FACTORS: Who gets them and why. You are going to ACE this one…

COVID-19 RISK FACTORS: Who gets them and why. You are going to ACE this one…

April 3, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Now usually I don’t go and make wild conjectures and hypotheses. But Im going to discuss a pretty interesting (wild conjecture?) one that on paper seems to make sense to me. Let’s look at the COVID-19 risk factors for who gets severe disease and put them in a molecular and biological framework. If you want you …

Category: DEEP DIVETag: Infectious Diseases

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 7
  • Next Page »

Site Footer

RSS
Follow by Email
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet
LinkedIn
LinkedIn
Share
Instagram

Copyright © 2022 · All Rights Reserved · Powered by Mai Theme

 

Loading Comments...